They demonstrate a favorable safety profile, allowing for co-administration with most other glucose-lowering medications, except vildagliptin
Hathcock, J
doi: 10.3389/fnagi.2016.00108 Received 21 March 2016 Accepted 26 April 2016 Published 24 May 2016 Volume 8 - 2016 Edited by Naoyuki Sato, Osaka University, Japan Reviewed by Christian Hlscher, Lancaster University, UK
Synergistic integration: CBDAs efficacy is enhanced in the context of the plants full chemical matrix, including terpenes and minor cannabinoids, reflecting the entourage effect
It mimics hormones that control blood sugar and satiety, helping to reduce hunger while slowing the rate at which food empties from your stomach
The main difference is that NovoCare offers a lower cash-pay option for eligible patients